Comparison of Treatment Guidelines for Ulcerative Colitis: Role of Biologics

Comparison of Treatment Guidelines for Ulcerative Colitis: Role of Biologics

Ulcerative colitis (UC) is a chronic inflammatory condition of the colon, characterized by diffuse mucosal inflammation with bloody diarrhea. The therapeutic goals in UC have evolved from symptomatic relief to deep remission, including sustained steroid-free clinical remission, mucosal healing, and...

Full description

Bibliographic Details
Main Authors:	Jung Ho Bae, Dong-Hoon Yang
Format:	Article
Language:	English
Published:	Jin Publishing & Printing Co. 2018-04-01
Series:	The Korean Journal of Gastroenterology
Subjects:	Ulcerative colitis Tumor necrosis factor-alpha Biological products
Online Access:	http://www.kjg.or.kr/journal/view.html?doi=10.4166/kjg.2018.71.4.192

Similar Items

Golimumab Therapy in Ulcerative Colitis
by: Won Moon
Published: (2016-02-01)

Diagnosis and Treatment of Ulcerative Colitis with Cytomegalovirus Infection: Importance of Controlling Mucosal Inflammation to Prevent Cytomegalovirus Reactivation
by: Hiroshi Nakase, et al.
Published: (2014-01-01)

Exploring the Relationship between Biologics and Postoperative Surgical Morbidity in Ulcerative Colitis: A Review
by: Abel Botelho Quaresma, et al.
Published: (2021-02-01)

Association between serum tumor necrosis factor-alpha level and the efficacy of infliximab for refractory pouchitis after restorative proctocolectomy in patients with ulcerative colitis
by: Motoi Uchino, et al.
Published: (2017-10-01)

Therapeutic effect of adenosine on experimentally induced acute ulcerative colitis model in rats
by: Gulcin Ercan, et al.
Published: (2020-02-01)

Role of dietary maize formulations in the healing of experimental acetic acid induced ulcerative colitis in male rats
by: Serah Funke Ige, et al.
Published: (2020-01-01)

Thrombotic cutaneous gangrene associated with ulcerative colitis
by: Justine Galambus, BS, et al.
Published: (2022-10-01)

Clinical Features and Therapeutic Outcomes of Post-colectomy Enteritis with Ulcerative Colitis
by: Yuki Horio, et al.
Published: (2021-10-01)

Rectal polypoid Inflammatory Myofibroblastic Tumor in 39-year-old liver transplant recipient with de-novo ulcerative colitis: A case report and literature review
by: Taylor D. Salisbury, et al.
Published: (2018-06-01)

Rectal tuberculosis after infliximab therapy despite negative screening for latent tuberculosis in a patient with ulcerative colitis
by: Jatinderpal Singh, et al.
Published: (2016-04-01)

Sustained Corticosteroid-Free Clinical Remission During Vedolizumab Maintenance Therapy in Patients with Ulcerative Colitis on Stable Concomitant Corticosteroids During Induction Therapy: A Post Hoc Analysis of GEMINI 1
by: Loftus EV Jr, et al.
Published: (2020-06-01)

Histone deacetylase inhibitor givinostat has ameliorative effect in the colitis model
by: Cengiz Dibekoğlu, et al.
Published: (2022-07-01)

Living with Ulcerative Colitis in Japan: Biologic Persistence and Health-Care Resource Use
by: Danielle Bargo, et al.
Published: (2021-11-01)

Effects of Silibin Nanocapsules on Acetic Acid Induced Ulcerative Colitis in Rats
by: Mohsen Minaiyan, et al.
Published: (2013-07-01)

Clinical, biochemical, endoscopic and histopathological evaluation of biological treatment in ulcerative colitis
by: Carlos A. López-Bernal, et al.
Published: (2022-10-01)

The Role of AMPK Signaling in Ulcerative Colitis
by: Yuan Y, et al.
Published: (2023-12-01)

Successful Response to Golimumab in a Case of Relapsing Polychondritis Overlapping with Ulcerative Colitis
by: Kojima S, et al.
Published: (2024-01-01)

Necrosis avascular de ambas caderas y rodillas en una paciente con colitis ulcerosa tratada prolongadamente con corticoides a dosis altas A vascular necrosis of both hips and knees in a patient with ulcerative colitis treated for a long term with high-dose corticosteroids
by: A. Vidal Casariego, et al.
Published: (2006-02-01)

Infliximab use in ulcerative colitis flare with clostridium difficile infection: A report of two cases and literature review
by: Bhupinder S. Romana, et al.
Published: (2018-09-01)

Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis
by: Pugliese D, et al.
Published: (2016-02-01)

Second Korean Guideline for the Management of Ulcerative Colitis
by: Chang Hwan Choi, et al.
Published: (2017-01-01)

ULCERATIVE COLITIS IN CHILDREN
by: Florea Iordăchescu
Published: (2009-03-01)

Prediction of long-term remission in patients following discontinuation of anti-TNF therapy in ulcerative colitis: a 10 year follow up study
by: Kay-Martin Johnsen, et al.
Published: (2022-11-01)

Second Korean guidelines for the management of ulcerative colitis
by: Chang Hwan Choi, et al.
Published: (2017-01-01)

Therapeutic effects of vitamin D on acetic acid-induced colitis in rats
by: Refik Bademci, et al.
Published: (2020-06-01)

Understanding patient journey in ulcerative colitis prior to biologic initiation: a 5-year exploration
by: Yiting Wang, et al.
Published: (2021-03-01)

Role of Loop Ileostomy in the Management of Ulcerative Colitis Patients
by: Ahmed N. Hussein
Published: (2020-01-01)

Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis
by: Soo-Young Na, et al.
Published: (2023-01-01)

Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?
by: Viscido A, et al.
Published: (2019-04-01)

Network meta-analysis on efficacy and safety of different biologics for ulcerative colitis
by: Xinqiao Chu, et al.
Published: (2023-10-01)

Managing ulcerative colitis after surgery
by: Cristina Calvino-Suarez, et al.
Published: (2023-01-01)

Fecal sST2 correlates with the disease severity of ulcerative colitis
by: Jovanović Marina, et al.
Published: (2019-01-01)

Identification of key genes and biological processes contributing to colitis associated dysplasia in ulcerative colitis
by: Di Zhang, et al.
Published: (2021-04-01)

Cytomegalovirus and Inflammatory Bowel Diseases (IBD) with a Special Focus on the Link with Ulcerative Colitis (UC)
by: Alexandre Jentzer, et al.
Published: (2020-07-01)

Tacrolimus versus anti-tumor necrosis factor agents for steroid-refractory active ulcerative colitis based on the severity of endoscopic findings: a single-center, open-label cohort study
by: Matsumoto S, et al.
Published: (2017-09-01)

Efficacy of sigmoidoscopy for evaluating disease activity in patients with ulcerative colitis
by: Su Bum Park, et al.
Published: (2022-02-01)

Ulcerative colitis: Al-gassim experience
by: Contractor Qais, et al.
Published: (2004-01-01)

Discrete terminal ileal ulcers in patients diagnosed with ulcerative colitis: clinical significance and natural course
by: Hyo-Jin Lim, et al.
Published: (2021-07-01)

Ulcerative Colitis and Acute Severe Ulcerative Colitis Patients Are Overlooked in Infliximab Population Pharmacokinetic Models: Results from a Comprehensive Review
by: Alix Démaris, et al.
Published: (2022-09-01)

Efficacy of biologic therapies for biologic-naïve Japanese patients with moderately to severely active ulcerative colitis: a network meta-analysis
by: Toshifumi Hibi, et al.
Published: (2021-01-01)